Literature DB >> 22429483

Impaired monocyte activation in schizophrenia.

Norbert Müller1, Jenny K Wagner, Daniela Krause, Elif Weidinger, Agnes Wildenauer, Michael Obermeier, Sandra Dehning, Rudolf Gruber, Markus J Schwarz.   

Abstract

An inflammatory process is hypothesized in schizophrenia. Innate immunity, in particular the monocyte/macrophage system, has rarely been studied in this disorder, although alterations in microglia indicate a role for this system. Increased monocyte numbers have repeatedly been described. Toll-like receptors (TLRs) mediate the activation of monocytes. We studied the expression of the toll-like receptors TLR-2, TLR-3 and TLR-4 on CD14(+) monocytes in 31 schizophrenia patients and 31 sex- and age-matched healthy controls. Blood samples were taken and stimulated with either lipopolysaccharides (LPS), to mimic a bacterial infection, or polyI:C, to mimic a viral infection. Moreover, the intracellular concentration of interleukin-1ß (IL-1ß) in CD33(+) monocytes was estimated before and after stimulation. The intracellular concentrations of IL-1ß and the TLR surface markers were analyzed by flow cytometry. Receptor expression of TLR-3 and TLR-4, but not of TLR-2, was significantly higher in the schizophrenia patients. After stimulation, patients showed less increase in the expression of TLR-3 and TLR-4 than controls did. The IL-1ß concentration was significantly lower in patients both before and after stimulation with polyI:C, and there was a trend towards a lower concentration after LPS stimulation. The higher expression of TLR-3 and TLR-4 receptors might compensate for a functional deficit, and the lower intracellular concentrations of IL-1ß might reflect the blunted monocytic function in schizophrenia. The immunological dysfunctions might be associated with a poor clearance of pathogens in schizophrenia, which in turn could lead to a low-grade inflammatory process.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22429483     DOI: 10.1016/j.psychres.2011.12.049

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  24 in total

1.  Monocyte activation detected prior to a diagnosis of schizophrenia in the US Military New Onset Psychosis Project (MNOPP).

Authors:  Natalya S Weber; Kristin L Gressitt; David N Cowan; David W Niebuhr; Robert H Yolken; Emily G Severance
Journal:  Schizophr Res       Date:  2018-01-06       Impact factor: 4.939

2.  Impaired monocyte activation in schizophrenia: ultrastructural abnormalities and increased IL-1β production.

Authors:  Natalya A Uranova; P D Bonartsev; L V Androsova; V I Rakhmanova; V G Kaleda
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-17       Impact factor: 5.270

3.  Increased circulating regulatory T cells in medicated people with schizophrenia.

Authors:  Deanna L Kelly; Xin Li; Catherine Kilday; Stephanie Feldman; Sarah Clark; Fang Liu; Robert W Buchanan; Leonardo H Tonelli
Journal:  Psychiatry Res       Date:  2018-09-05       Impact factor: 3.222

4.  Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Cassie R Stallings; Andrea E Origoni; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken
Journal:  Schizophr Res       Date:  2013-06-06       Impact factor: 4.939

5.  Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.

Authors:  Li-Jin Chew; Paolo Fusar-Poli; Thomas Schmitz
Journal:  Dev Neurosci       Date:  2013-02-27       Impact factor: 2.984

Review 6.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

Review 7.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

8.  Associations Between Maternal Infection During Pregnancy, Childhood Infections, and the Risk of Subsequent Psychotic Disorder--A Swedish Cohort Study of Nearly 2 Million Individuals.

Authors:  Åsa Blomström; Håkan Karlsson; Renee Gardner; Lena Jörgensen; Cecilia Magnusson; Christina Dalman
Journal:  Schizophr Bull       Date:  2015-08-24       Impact factor: 9.306

Review 9.  Evidence for a dysregulated immune system in the etiology of psychiatric disorders.

Authors:  Sinead M Gibney; Hemmo A Drexhage
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-05       Impact factor: 4.147

10.  Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia.

Authors:  Borja García-Bueno; Patricia Gassó; Karina S MacDowell; Luis F Callado; Sergi Mas; Miguel Bernardo; Amalia Lafuente; J Javier Meana; Juan C Leza
Journal:  J Psychiatry Neurosci       Date:  2016-04       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.